AMPK和O-GlcNAcylation:在心脏病理和心力衰竭中的相互作用
Ettore Vanni1, Christophe Beauloye1,2, Sandrine Horman1
1Pole of Cardiovascular Research, Institute of Experimental and Clinical Research (IREC), UCLouvain, Brussels, Belgium.
Essays in biochemistry
|September 25, 2024
概括
心力衰竭 (HF) 涉及复杂的分子变化. 本综述探讨了AMP激活蛋白激酶 (AMPK) 和O-GlcNAcylation如何影响HF中的心脏功能和新陈代谢.
科学领域:
- 生物化学 生化学
- 心脏病学 心脏病学
- 分子生物学分子生物学
背景情况:
- 心力衰竭 (HF) 是一个重要的全球健康问题,患病率和死亡率很高.
- 尽管医学取得了进步,但在分子层面上理解高频率病原体至关重要.
- AMP激活蛋白激酶 (AMPK) 和O-GlcNAcylation与细胞能量调节有关.
研究的目的:
- 审查AMPK和O-GlcNAcylation在心力衰竭中的作用.
- 阐明这些途径在HF中的相互作用和失调.
- 突出针对AMPK和O-GlcNAcylation的治疗策略在高频中.
主要方法:
- 关于临床前和临床研究的综合文献综述.
- 分析涉及AMPK和O-GlcNAcylation在心脏功能中的分子机制.
- 检查与心脏能量,新陈代谢和重塑相关的信号通路.
主要成果:
- AMPK和O-GlcNAcylation是心脏新陈代谢和能量学的关键调节者.
- 这些通路的失调有助于心力衰竭的进展.
- 向AMPK和O-GlcNAcylation显示出新型HF疗法的潜力.
结论:
- AMPK和O-GlcNAcylation通路在心力衰竭的发病过程中具有关键作用.
- 了解它们复杂的机制为HF提供了新的治疗途径.
- 对这些分子标的进一步研究可能会改善高频管理.
更多相关视频
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
cAMP-dependent Protein Kinase Pathways
6.2K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.2K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Pathophysiology of Cardiac Performance
601
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
601
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Heart Failure Drugs: Inotropic Agents
539
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
539


